Gene Therapy for the treatment of human Disease Network (GeneHumdi | COST action CA21113) is assembled from peers like you: academia and industry scientist, translational scientist, clinicians, regulatory agents, and industry partners. If you too are passionate about the improvement and translation of Gene Editing protocols to treat diseases lacking sound medical care or susceptible of increase safety and control of the therapeutic interventions through the implementation of precision gene medicine, join us.
Become a COST member in the COST website and join the GeneHumdi CA21113 Cost Action.
We strongly recommend you contacting the WG leaders of your areas of interest to know whether you can contribute with ongoing task and joint in forces to have your voice represented in the future guidelines.
Alternatively consider our Training School, and courses as a first contact and join our social media to stay in touch.
